The EGFR-GEP100-Arf6 pathway in breast cancer: Full invasiveness is not from the inside

Por Sabe, Hisataka, Hashimoto, Shigeru, Morishige, Masaki, Hashimoto, Ari, Ogawa, Eiji
Publicado em 2008

The EGFR-GEP100-Arf6-AMAP1 Signaling Pathway Specific to Breast Cancer Invasion and Metastasis(†)

Por Sabe, Hisataka, Hashimoto, Shigeru, Morishige, Masaki, Ogawa, Eiji, Hashimoto, Ari, Nam, Jin-Min, Miura, Koichi, Yano, Hajime, Onodera, Yasuhito
Publicado em 2009

The Potentiality for Development of Multiple Dural Arteriovenous Fistulas after Ligation of the Internal Jugular Vein: A Case Report

Por Fudaba, Hirotaka, Kubo, Takeshi, Goda, Makoto, Sugita, Kenji, Morishige, Masaki, Onishi, Kouhei, Ishii, Keisuke, Anan, Mitsuhiro, Nagai, Yasuyuki, Fujiki, Minoru
Publicado no NMC Case Rep J (2017)

Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities

Por Onodera, Yasuhito, Hashimoto, Shigeru, Hashimoto, Ari, Morishige, Masaki, Mazaki, Yuichi, Yamada, Atsuko, Ogawa, Eiji, Adachi, Masashi, Sakurai, Takaki, Manabe, Toshiaki, Wada, Hiromi, Matsuura, Nariaki, Sabe, Hisataka
Publicado em 2005

GEP100-Arf6-AMAP1-Cortactin Pathway Frequently Used in Cancer Invasion Is Activated by VEGFR2 to Promote Angiogenesis

Por Hashimoto, Ari, Hashimoto, Shigeru, Ando, Ryo, Noda, Kosuke, Ogawa, Eiji, Kotani, Hirokazu, Hirose, Mayumi, Menju, Toshi, Morishige, Masaki, Manabe, Toshiaki, Toda, Yoshinobu, Ishida, Susumu, Sabe, Hisataka
Publicado em 2011

Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasis

Por Hashimoto, Shigeru, Hirose, Mayumi, Hashimoto, Ari, Morishige, Masaki, Yamada, Atsuko, Hosaka, Harumi, Akagi, Ken-ichi, Ogawa, Eiji, Oneyama, Chitose, Agatsuma, Tsutomu, Okada, Masato, Kobayashi, Hidenori, Wada, Hiromi, Nakano, Hirofumi, Ikegami, Takahisa, Nakagawa, Atsushi, Sabe, Hisataka
Publicado em 2006